| Literature DB >> 29443094 |
Sandra B Lemke1, Frank Schnorrer2.
Abstract
Muscles together with tendons and the skeleton enable animals including humans to move their body parts. Muscle morphogenesis is highly conserved from animals to humans. Therefore, the powerful Drosophila model system can be used to study concepts of muscle-tendon development that can also be applied to human muscle biology. Here, we describe in detail how morphogenesis of the adult muscle-tendon system can be easily imaged in living, developing Drosophila pupae. Hence, the method allows investigating proteins, cells and tissues in their physiological environment. In addition to a step-by-step protocol with helpful tips, we provide a comprehensive overview of fluorescently tagged marker proteins that are suitable for studying the muscle-tendon system. To highlight the versatile applications of the protocol, we show example movies ranging from visualization of long-term morphogenetic events - occurring on the time scale of hours and days - to visualization of short-term dynamic processes like muscle twitching occurring on time scale of seconds. Taken together, this protocol should enable the reader to design and perform live-imaging experiments for investigating muscle-tendon morphogenesis in the intact organism.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29443094 PMCID: PMC5912364 DOI: 10.3791/57312
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355





|
|
|
|
|
|
|
|
|
| all myoblasts and all muscles at all stages | GAL4 line | BL 27390 |
| ||
| adult muscle precursors and early myotubes until ≈24 h APF | GAL4 line, enhancer trap | - |
| |||
| jump muscle upon differentiation | GAL4 line | - |
| |||
| indirect flight muscles starting ≈14 h APF | GAL4 line | - |
| |||
| indirect flight muscles starting ≈14 h APF | Act88F enhancer/ promoter driving Cameleon 3.1 | - | Ca2+ indicator |
| ||
| Act88F-GFP | indirect flight muscles starting ≈14 h APF | GFP-fusion (fly TransgeneOme line) | fTRG78 and fTRG10028 |
| ||
| adult muscle precursors, nuclear, until ≈24 h APF in indirect flight muscles | enhancer/promoter with nls-GFP reporter | - | 1.5 kb enhancer fragment |
| ||
| microtubules in DLM templates and in differentiating muscles | enhancer/promoter with Tau-GFP reporter | BL 53739 |
| |||
| βTub60D-GFP | microtubules in myotubes (e.g. in indirect flight muscles from ≈14 h AFP, strongly decreasing after ≈48 h APF) | GFP-fusion (fly TransgeneOme line) | fTRG958 |
| ||
| Mhc-GFP (weeP26) | sarcomeres (thick filament) in all body muscles (e.g. in indirect flight muscles starting from ≈30 h APF) | GFP-trap | - | use heterozygous, labels an isoform subset |
| |
| Sls-GFP | sarcomeres (Z-disc) in all body muscles (e.g. in indirect flight muscles starting from ≈30 h APF) | GFP-trap (FlyTrap line) | - | G53, use heterozygous |
| |
| Zasp66-GFP | Z-disc in all body muscles | GFP-trap (FlyTrap line) | BL 6824 | ZCL0663 |
| |
| Zasp52-GFP | Z-disc in all body muscles | GFP-trap (FlyTrap line) | BL 6838 | G00189 |
| |
| Hts-GFP | actin binding; expressed in epithelium, myoblasts and myotubes | GFP-fusion (fly TransgeneOme line) | fTRG585 |
| ||
| Dlg1-GFP | epithelial cell junctions, myoblasts and membranes in muscles at all stages | GFP-fusion (fly TransgeneOme line) | fTRG502 |
| ||
|
| βPS-Integrin-GFP | muscle attachment sites (e.g., starting ≈18 h AFP in indirect flight muscles) | GFP-knock-in | - |
| |
| Talin-GFP and -mCherry | muscle attachment sites (e.g., starting ≈18 h AFP in indirect flight muscles) | GFP-trap (MiMIC line) | - |
| ||
| Talin-GFP | muscle attachment sites (e.g., starting ≈18 h AFP in indirect flight muscles) | GFP-fusion (fly TransgeneOme line) | fTRG587 |
| ||
| Ilk-GFP | muscle attachment sites (e.g., starting ≈18 h AFP in indirect flight muscles) | GFP-trap (FlyTrap line) | Kyoto 110951 (ZCL3111) | ZCL3111, ZCL3192 |
| |
| Vinc-GFP and -RFP | muscle attachment sites (e.g., starting ≈18 h AFP in indirect flight muscles) | GFP-fusion (transgene) | - |
| ||
|
| thorax tendon cells, throughout pupal stage | GAL4 line, enhancer trap | BL 26663 | homozygous lethal |
| |
|
| muscles and epithelia, early onset | GAL4 line | BL 66682 | kirre-rP298, founder cell marker |
| |
|
| actin binding | UAS line | BL 31776 | actin binding domain of Moesin fused to GFP |
| |
| actin binding | UAS line | - | Gma fused to mCherry |
| ||
| actin binding | UAS line | BL 35544 |
| |||
| actin binding | UAS line | BL 35545 |
| |||
| membrane binding | UAS line | various stocks, e.g.: BL 32184 |
| |||
| membrane binding | UAS line | BL 27391 and 27392 |
| |||
| membrane binding through palmitoylation | UAS line | BL 34514 |
|